Enovix (ENVX) Q4 2024 earnings summary

Executive summary

• Q4 2024 revenue reached $9.7 million, near the high end of guidance; full-year 2024 revenue was $23.1 million, up from $7.6 million in 2023, a 202% increase.

• Major milestones included completing Site Acceptance Testing (SAT) of the high-volume manufacturing line in Malaysia and shipping first EX-2M samples to customers, with multiple OEMs initiating factory audits.

• Early engineering samples for a lead smartphone OEM passed critical safety tests, with commercial smartphone launches targeted for 2025 pending qualification; engagements expanded to 7 of top 8 smartphone OEMs.

• Secured a landmark prepaid order for XR batteries from a global AI/immersive tech leader, with first samples delivered and production capacity reserved.

• Ended 2024 with $273 million in cash and cash equivalents, providing flexibility for further manufacturing expansion.

Financial highlights

• Q4 2024 revenue was $9.7 million, above the midpoint of guidance, and full-year revenue was $23.1 million.

• Achieved first-ever positive gross margin in Q4: $1.1 million or 11% of sales.

• Non-GAAP EBITDA loss for Q4 was $11.7 million, outperforming guidance of a $19–$25 million loss.

• Non-GAAP EPS loss was $0.11, better than guidance of $0.15–$0.21 loss; Q4 GAAP EPS loss was $0.20.

• Ended Q4 with $273 million in cash and cash equivalents, bolstered by $107 million net equity offering proceeds.

Outlook and guidance

• Q1 2025 revenue forecast is $3.5–$5.5 million.

• Adjusted EBITDA loss expected at $21–$27 million; non-GAAP EPS loss of $0.15–$0.21; Q1 2025 GAAP EPS loss forecasted at $0.23 to $0.29.

• High-volume smartphone production in Malaysia targeted for Q4 2025, with full utilization of first HVM line in 2026.

• 2025 CapEx budgeted at $30–$40 million.